QP-Prostate® CAD vs QUIBIM Precision Prostate (qp-Prostate)
AI Verdict
Choose QP-Prostate® CAD if…
Choose QP-Prostate® CAD if your primary focus is on the precise detection and risk scoring of clinically significant prostate cancer, leveraging advanced quantitative perfusion metrics (K trans, K ep, V e) and 3D visualization for in-depth diagnostic assessment. This cloud-based solution is particularly suited for radiologists who require detailed insights from AI trained on actual pathology/biopsy data.
View QP-Prostate® CAD →Choose QUIBIM Precision Prostate (qp-Prostate) if…
Choose QUIBIM Precision Prostate (qp-Prostate) if your clinical workflow extends beyond diagnosis to include direct support for fusion biopsy and focal therapy planning. This tool offers versatile deployment options, including on-premise, making it ideal for health systems seeking an adaptable AI solution for aggressive prostate cancer stratification and treatment pathway integration.
View QUIBIM Precision Prostate (qp-Prostate) →When considering AI tools for prostate MRI interpretation, physicians have two options from Quibim S.L.: QP-Prostate® CAD and QUIBIM Precision Prostate (qp-Prostate). Both are FDA-cleared and aim to enhance diagnostic accuracy and streamline radiology workflows for prostate cancer detection. Both tools offer automated prostate segmentation, AI-driven lesion detection, and PI-RADS compliant reporting, along with AI-QUAL™ for image quality assessment.
The key practical difference lies in their feature sets and deployment. QP-Prostate® CAD provides more extensive quantitative information, including prostate volume and dimensions, computed high b-value, and perfusion metrics (K trans, K ep, V e), alongside advanced 3D visualization. It is cloud-based with integration into standard reading environments and AI marketplaces. In contrast, QUIBIM Precision Prostate focuses on aggressive lesion detection and stratification, and offers support for both fusion biopsy and focal therapy planning, with deployment options for on-premise (standard workstation compatible) and cloud-integrated systems.
A physician prioritizing comprehensive quantitative analysis, advanced visualization, and cloud-based deployment for broader integration might lean towards QP-Prostate® CAD. Conversely, a physician seeking robust support for fusion biopsy and focal therapy planning, with the flexibility of on-premise deployment, may find QUIBIM Precision Prostate to be a more suitable choice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | QP-Prostate® CAD | QUIBIM Precision Prostate (qp-Prostate) |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Cloud-based, with integration into standard reading environments (PACS) and AI marketplaces. | On-premise (standard workstation compatible) and cloud-integrated for large health systems. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
QP-Prostate® CADTool A explicitly mentions an 'Upgraded user interface' and 'Advanced viewing with 3D visualization,' along with 'Flexible overlays: optional, adjustable, and removable AI-generated findings,' suggesting a more refined and user-friendly experience. While both tools integrate with PACS, Tool A's detailed description of UI enhancements points to a superior focus on usability.
Clinical Value
QP-Prostate® CADBoth tools offer automated lesion detection, prostate segmentation, and PI-RADS compliant reporting. However, Tool A provides more extensive quantitative information, including computed high b-value and perfusion metrics (K trans, K ep, V e), which can offer deeper insights for diagnosis and treatment planning. Tool A also specifically mentions 'risk scoring (High and Moderate) for clinically significant prostate cancer (csPCa),' further enhancing its clinical utility.
Pricing & Value
TieBoth tools state 'contact for pricing' or 'contact vendor,' indicating a lack of transparent, publicly available pricing information. Without specific details on cost or licensing models, it is impossible to determine which tool offers better value.
Enterprise Readiness
TieBoth tools are FDA-cleared, HIPAA compliant, and offer BAA, demonstrating a strong foundation for enterprise deployment. Tool A specifies 'Cloud-based, with integration into standard reading environments (PACS) and AI marketplaces,' while Tool B mentions 'On-premise (standard workstation compatible) and cloud-integrated for large health systems.' Both deployment options cater to enterprise needs, making it a tie.
Innovation
QP-Prostate® CADWhile both tools share core innovative features like AI-QUAL™ for image quality assessment and AI-driven lesion detection, Tool A's inclusion of 'Advanced viewing with 3D visualization' and a broader range of quantitative perfusion metrics suggests a slight edge in pushing the boundaries of current capabilities. Additionally, Tool A's algorithms are trained on actual pathology/biopsy data, which is a significant advancement for diagnostic accuracy.
Support & Docs
TieNeither the provided structured facts nor web search results offer specific details regarding the level of customer support, training, or documentation available for either tool. Without this information, it is not possible to distinguish between the two products in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | QP-Prostate® CAD | QUIBIM Precision Prostate (qp-Prostate) |
|---|---|---|
| Name | QP-Prostate® CAD | QUIBIM Precision Prostate (qp-Prostate) |
| Company | Quibim S.L. | QUIBIM S.L. |
| Key Feature: Automated Lesion Detection | Automatic lesion detection and risk scoring (High and Moderate) for clinically significant prostate cancer (csPCa) | AI algorithm for detection and stratification of aggressive prostate cancer lesions |
| Key Feature: Prostate Segmentation | Prostate segmentation (peripheral zone, transitional and central zone, seminal vesicles) | Automated prostate segmentation (peripheral zone, transitional/central zone, seminal vesicles) |
| Key Feature: MRI Image Quality Assessment | AI-QUAL™ for automated prostate MRI image quality assessment based on PI-QUAL v2 guidelines | AI-QUAL™ for automated prostate MRI image quality assessment (PI-QUAL v2 guidelines) |
| Key Feature: Structured Reporting | PI-RADS 2.1 structured report template | PI-RADS compliant structured reporting |
| Key Feature: Fusion Biopsy Integration | Seamless integration into PACS and fusion biopsy systems | Support for fusion biopsy planning; Seamless integration with PACS and fusion biopsy systems |
| Key Feature: Quantitative Information/Analysis | Quantitative information: prostate volume and dimensions, Apparent Diffusion Coefficient (ADC) map, computed high b-value and perfusion metrics (K trans, K ep, V e) | Automated diffusion and perfusion analysis (ADC map, synthesized b-1400s/mm2) |
Videos
Demos, reviews, and walkthroughs featuring QP-Prostate® CAD and QUIBIM Precision Prostate (qp-Prostate).
Frequently Asked Questions
More Comparisons
More matchups featuring QP-Prostate® CAD or QUIBIM Precision Prostate (qp-Prostate)
Backers
Who funded each tool's parent company.